Last Updated: May 10, 2026

MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Monobasic Sodium Phosphate And Dibasic Sodium Phosphate, and when can generic versions of Monobasic Sodium Phosphate And Dibasic Sodium Phosphate launch?

Monobasic Sodium Phosphate And Dibasic Sodium Phosphate is a drug marketed by Novel Labs Inc and is included in one NDA.

The generic ingredient in MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE is sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE?
  • What are the global sales for MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE?
  • What is Average Wholesale Price for MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE?
Summary for MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE at DailyMed
Pharmacology for MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE

US Patents and Regulatory Information for MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate TABLET;ORAL 079247-001 Dec 30, 2011 RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Monobasic Sodium Phosphate and Dibasic Sodium Phosphate

Last updated: February 23, 2026

What are the primary uses and industry demand drivers?

Monobasic sodium phosphate (MSP) and dibasic sodium phosphate (DSP) are inorganic salts used mainly in food packaging, water treatment, pharmaceuticals, and industrial cleaning. Their applications are driven by regulations on food additives, pharmaceutical formulations, and water safety standards.

How is the pharmaceutical industry influencing growth?

Pharmaceutical manufacturing uses MSP and DSP as excipients in drugs, especially in buffered solutions and laxatives. The aging global population and rising chronic illnesses support increased production of phosphate-based pharmaceuticals. Market growth correlates with pharmaceutical R&D investments and regulatory approvals for new formulations.

How do food and beverage industries impact market trends?

Regulations governing food safety and additive labeling affect demand. Monobasic and dibasic sodium phosphates function as leavening agents, emulsifiers, and acidity regulators. The trend toward clean-label ingredients constrains usage but does not significantly impair overall demand due to their widespread applications. Growth in processed food consumption especially in emerging markets contributes to increased phosphate additive use.

What are the key regional market factors?

  • North America: Established food and pharma sectors; stringent regulations motivate innovation but limit excessive use.
  • Europe: Regulatory restrictions on phosphate levels in foods reduce growth but sustain pharmaceutical and industrial applications.
  • Asia-Pacific: Rapid urbanization, population growth, expanding processed food markets, and pharmaceutical sector expansion lead to higher demand. China and India dominate regional consumption.

What market forces are shaping pricing trends?

Supply and demand fluctuations heavily influence phosphate pricing. Raw material availability and environmental regulations on mining and manufacturing raise costs. Industry consolidation in Asia-Pacific impacts pricing stability. Prices of MSP and DSP have increased by approximately 4–6% annually over the past five years.

Which companies dominate the market?

Major players include:

  • Innophos Holdings
  • phosphate producers in China and India
  • Yara International
  • Prayon Group

These companies maintain control through vertical integration and long-term supply contracts.

How are regulatory policies affecting market access?

Environmental and health safety regulations impact production. The European Union imposes limitations on phosphate additives in food, affecting market volume. Import tariffs and export restrictions modulate trade flows, especially between China and Western markets.

What are the revenue projections for the next five years?

Global market size was valued at approximately $850 million in 2022. Compound annual growth rate (CAGR) estimates range from 3% to 5% through 2028. Growth is driven by pharmaceutical and industrial segment expansion, with food additive use stabilizing due to regulatory pressures.

Year Estimated Market Size (USD million) CAGR (%)
2023 $880
2024 $915 4.0
2025 $950 3.8
2026 $985 3.7
2027 $1,020 3.8
2028 $1,055 3.7

What are key risks and opportunities?

Risks:

  • Regulatory shifts potentially reducing permissible phosphate levels.
  • Volatility in raw material costs.
  • Political uncertainties affecting trade.

Opportunities:

  • Growing demand in emerging markets.
  • Innovation in pharmaceutical formulations.
  • Increased water treatment needs globally.

Key Takeaways

  • Demand for MSP and DSP stems from pharmaceutical, food, and industrial applications.
  • Market growth persists locally driven but moderated by regional regulations.
  • Prices are influenced by raw material costs, regulations, and supply chain dynamics.
  • The market is consolidated, with top players controlling supply channels.
  • The industry faces regulatory challenges but also benefits from the expanding pharmaceutical and industrial sectors.

FAQs

1. What are the primary applications of MSP and DSP?
They serve as food additives, pharmaceutical excipients, water treatment chemicals, and industrial cleaners.

2. Which regions are experiencing the highest growth?
Asia-Pacific, driven by expanding processed food, pharmaceutical, and industrial sectors, shows the fastest growth.

3. How do regulations impact the use of phosphate-based chemicals?
Strict limits on phosphate levels in foods and environmental regulations restrict usage, especially in Europe.

4. Will prices of MSP and DSP increase or decrease?
Prices are projected to escalate modestly, averaging 3–4% annually, influenced by raw material costs and regulatory changes.

5. What are the prospects for new product development?
Growth in pharmaceutical formulations and water treatment solutions offers opportunities for innovation in phosphate applications.

References

  1. Innophos Holdings. (2022). Annual Report.
  2. Yara International. (2022). Market Analysis Report.
  3. European Food Safety Authority. (2021). Scientific Opinion on Phosphates.
  4. Asian Chemical Industry Association. (2022). Market Dynamics and Trends.
  5. Prayon Group. (2021). Product Portfolio and Market Strategy.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.